AI sovereignty

Digital

Reliance on US big tech is now being challenged around the world at a time when geopolitical instability is eroding global trust in US leadership.

Digital

The companies that will lead in this next phase are those that treat AI as an integrated part of their operational architecture.

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.